GeSIDA quality care indicators associated with mortality and hospital admission for the care of persons infected by HIV/AIDS

被引:3
作者
Delgado-Mejia, Elena [1 ]
Frontera-Juan, Guillem [1 ]
Murillas-Angoiti, Javier [1 ]
Abdon Campins-Rosello, Antoni [1 ]
Gil-Alonso, Leire [1 ]
Penaranda-Vera, Maria [1 ]
Ribas del Blanco, Maria Angels [1 ]
Luisa Martin-Pena, Maria [1 ]
Riera-Jaume, Melchor [1 ]
机构
[1] Hosp Univ Son Espases, Palma De Mallorca, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2017年 / 35卷 / 02期
关键词
Human immunodeficiency virus; Acquired immune deficiency syndrome; Human immunodeficiency syndrome care indicators; Mortality; Admission; ACTIVE ANTIRETROVIRAL THERAPY; ALL-CAUSE MORTALITY; HIV-INFECTION;
D O I
10.1016/j.eimc.2016.04.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: In 2010, the AIDS Study Group (Grupo de Estudio del SIDA [GESIDA]) developed 66 quality care indicators. The aim of this study is to determine which of these indicators are associated with mortality and hospital admission, and to perform a preliminary assessment of a prediction rule for mortality and hospital admission in patients on treatment and follow-up. Methods: A retrospective cohort study was conducted in the Hospital Universitario Son Espases (Palma de Mallorca, Spain). Eligible participants were patients with human immunodeficiency syndrome >= 18 years old who began follow-up in the Infectious Disease Section between 1 January 2000 and 31 December 2012. A descriptive analysis was performed to evaluate anthropometric variables, and a logistic regression analysis to assess the association between GESIDA indicators and mortality/admission. The mortality probability model was built using logistic regression. Results: A total of 1,944 adults were eligible (median age: 37 years old, 78.8% male). In the multivariate analysis, the quality of care indicators associated with mortality in the follow-up patient group were the items 7, 16 and 20, and in the group of patients on treatment were 7, 16, 20, 35, and 38. The quality of care indicators associated with hospital admissions in the follow-up patients group were the same as those in the mortality analysis, plus number 31. In the treatment group the associated quality of care indicators were items 7, 16, 20, 35, 38, and 40. Conclusions: Some GeSIDA quality of care indicators were associated with mortality and/or hospital admissions. These indicators are associated with delayed diagnosis, regular monitoring, prevention of infections, and control of comorbidities. (C) 2016 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 14 条
  • [1] Akgiin MM, 2013, J ACQUIR INMUNE DEFI, V62, P52
  • [2] The VACS Index Predicts Mortality in a Young, Healthy HIV Population Starting Highly Active Antiretroviral Therapy
    Bebu, Ionut
    Tate, Janet
    Rimland, David
    Mesner, Octavio
    Macalino, Grace E.
    Ganesan, Anuradha
    Okulicz, Jason F.
    Bavaro, Mary
    Weintrob, Amy C.
    Justice, Amy C.
    Agan, Brian K.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (02) : 226 - 230
  • [3] Delgado E, 2013, 5 CONGR GESIDA SITG, P47
  • [4] All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010
    Hernando, Victoria
    Alejos, Belen
    Monge, Susana
    Berenguer, Juan
    Anta, Lourdes
    Vinuesa, David
    Palacios, Rosario
    Muga, Roberto
    Moreno, Santiago
    Jarrin, Inma
    [J]. BMC INFECTIOUS DISEASES, 2013, 13
  • [5] Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers
    Justice, A. C.
    McGinnis, K. A.
    Skanderson, M.
    Chang, C. C.
    Gibert, C. L.
    Goetz, M. B.
    Rimland, D.
    Rodriguez-Barradas, M. C.
    Oursler, K. K.
    Brown, S. T.
    Braithwaite, R. S.
    May, M.
    Covinsky, K. E.
    Roberts, M. S.
    Fultz, S. L.
    Bryant, K. J.
    [J]. HIV MEDICINE, 2010, 11 (02) : 143 - 151
  • [6] Quality of HIV Care and Mortality Rates in HIV-Infected Patients
    Korthuis, Philip Todd
    McGinnis, Kathleen A.
    Kraemer, Kevin L.
    Gordon, Adam J.
    Skanderson, Melissa
    Justice, Amy C.
    Crystal, Stephen
    Goetz, Matthew Bidwell
    Gibert, Cynthia L.
    Rimland, David
    Fiellin, Lynn E.
    Gaither, Julie R.
    Wang, Karen
    Asch, Steven M.
    McInnes, Donald Keith
    Ohl, Michael E.
    Bryant, Kendall
    Tate, Janet P.
    Duggal, Mona
    Fiellin, David A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 62 (02) : 233 - 239
  • [7] Lanoy E, 2007, ANTIVIR THER, V12, P89
  • [8] Development and Validation of a Composite Programmatic Assessment Tool for HIV Therapy
    Lima, Viviane D.
    Le, Adrian
    Nosyk, Bohdan
    Barrios, Rolando
    Yip, Benita
    Hogg, Robert S.
    Harrigan, P. Richard
    Montaner, Julio S. G.
    [J]. PLOS ONE, 2012, 7 (11):
  • [9] CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression
    Moore, Richard D.
    Keruly, Jeanne C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (03) : 441 - 446
  • [10] Beyond Core Indicators of Retention in HIV Care: Missed Clinic Visits Are Independently Associated With All-Cause Mortality
    Mugavero, Michael J.
    Westfall, Andrew O.
    Cole, Stephen R.
    Geng, Elvin H.
    Crane, Heidi M.
    Kitahata, Mari M.
    Mathews, W. Christopher
    Napravnik, Sonia
    Eron, Joseph J.
    Moore, Richard D.
    Keruly, Jeanne C.
    Mayer, Kenneth H.
    Giordano, Thomas P.
    Raper, James L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (10) : 1471 - 1479